Royal Bank Of Canada Forecasts Strong Price Appreciation for The Pennant Group (NASDAQ:PNTG) Stock

The Pennant Group (NASDAQ:PNTG) had its target price upped by stock analysts at Royal Bank Of Canada from $34.00 to $39.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price target points to a potential upside of 49.48% from the company’s previous close.

PNTG has been the topic of several other reports. Wall Street Zen cut The Pennant Group from a “buy” rating to a “hold” rating in a report on Sunday. Stephens restated an “overweight” rating and set a $40.00 price target on shares of The Pennant Group in a report on Thursday, October 9th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of The Pennant Group in a report on Wednesday, November 5th. Wells Fargo & Company lowered their target price on The Pennant Group from $31.00 to $29.00 and set an “equal weight” rating for the company in a research report on Thursday, August 14th. Finally, Jefferies Financial Group assumed coverage on shares of The Pennant Group in a research report on Friday, October 24th. They issued a “buy” rating and a $30.00 price target on the stock. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $33.60.

The Pennant Group Price Performance

PNTG stock opened at $26.09 on Monday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The company’s fifty day moving average price is $24.89 and its 200-day moving average price is $25.80. The Pennant Group has a one year low of $21.18 and a one year high of $32.11. The company has a market capitalization of $902.45 million, a PE ratio of 34.79, a price-to-earnings-growth ratio of 2.06 and a beta of 1.39.

The Pennant Group (NASDAQ:PNTG) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.01. The company had revenue of $229.04 million for the quarter, compared to the consensus estimate of $221.96 million. The Pennant Group had a net margin of 3.15% and a return on equity of 9.37%. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. On average, equities analysts anticipate that The Pennant Group will post 0.75 EPS for the current fiscal year.

Institutional Investors Weigh In On The Pennant Group

Several institutional investors have recently made changes to their positions in PNTG. Quarry LP bought a new position in The Pennant Group during the 3rd quarter valued at about $37,000. State of Alaska Department of Revenue bought a new stake in The Pennant Group in the third quarter worth about $54,000. Tower Research Capital LLC TRC boosted its position in shares of The Pennant Group by 161.6% during the second quarter. Tower Research Capital LLC TRC now owns 3,987 shares of the company’s stock valued at $119,000 after buying an additional 2,463 shares during the period. AlphaQuest LLC bought a new position in shares of The Pennant Group during the third quarter valued at approximately $137,000. Finally, State of Wyoming raised its holdings in shares of The Pennant Group by 41.3% in the first quarter. State of Wyoming now owns 6,170 shares of the company’s stock worth $155,000 after buying an additional 1,803 shares during the period. Institutional investors own 85.88% of the company’s stock.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.